The Pakistani government has announced a plan to enforce stricter oversight on the pharmaceutical sector, aiming to regulate medicine prices, ensure the availability of essential drugs, and curb misleading advertisements. A coordinated framework between regulatory authorities will strengthen monitoring and accountability across the industry.
Under the new initiative, agencies will share information, conduct joint inspections, and take action against false or deceptive marketing practices. The oversight will also focus on maintaining transparency in drug supply chains and addressing complaints regarding shortages and inflated prices.
Key Objectives of the Oversight
- Price Regulation: Ensure fair pricing of medicines and prevent sudden or unjustified increases.
- Consumer Protection: Stop misleading advertisements and unsafe promotion practices.
- Supply Chain Transparency: Monitor the availability of essential drugs and prevent hoarding or shortages.
- Capacity Building: Strengthen regulatory frameworks and improve coordination between agencies.
Officials emphasized that the initiative is a critical step to safeguard public health, ensure accessibility of essential medicines, and restore trust in the pharmaceutical market. Citizens can expect more reliable pricing and safer access to medicines as enforcement measures roll out.
This story has been reported by PakTribune. All rights reserved.